Mar
29
More than 30,000 people a year are diagnosed with multiple myeloma in the United States, making it the second most common type of blood cancer. Researchers have yet to find a cure, in part due to the diverse ways the disease manifests itself, but recent advances in cancer research have made it a treatable disease.
The availability of genomic data and power of artificial intelligence is driving more progress in the understanding of multiple myeloma. Causal machine learning (causal ML) – a powerful form of artificial intelligence – has the ability to reduce the time to study disease and...
